Wedbush Securities’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-5,677
| Closed | -$307K | – | 1133 |
|
|
2024
Q2 | $307K | Buy |
5,677
+366
| +7% | +$19.8K | 0.01% | 851 |
|
|
2024
Q1 | $362K | Buy |
5,311
+1,153
| +28% | +$78.6K | 0.01% | 780 |
|
|
2023
Q4 | $260K | Buy |
+4,158
| New | +$260K | 0.01% | 833 |
|
|
2023
Q3 | – | Sell |
-3,767
| Closed | -$211K | – | 1064 |
|
|
2023
Q2 | $211K | Sell |
3,767
-1,188
| -24% | -$66.5K | 0.01% | 909 |
|
|
2023
Q1 | $224K | Buy |
+4,955
| New | +$224K | 0.01% | 893 |
|
|
2022
Q4 | – | Sell |
-5,656
| Closed | -$370K | – | 1067 |
|
|
2022
Q3 | $370K | Sell |
5,656
-3,043
| -35% | -$199K | 0.02% | 629 |
|
|
2022
Q2 | $529K | Hold |
8,699
| – | – | 0.03% | 510 |
|
|
2022
Q1 | $546K | Sell |
8,699
-506
| -5% | -$31.8K | 0.03% | 540 |
|
|
2021
Q4 | $698K | Buy |
9,205
+910
| +11% | +$69K | 0.03% | 497 |
|
|
2021
Q3 | $928K | Sell |
8,295
-263
| -3% | -$29.4K | 0.04% | 379 |
|
|
2021
Q2 | $1.39M | Sell |
8,558
-101
| -1% | -$16.3K | 0.07% | 278 |
|
|
2021
Q1 | $1.06M | Buy |
+8,659
| New | +$1.06M | 0.06% | 314 |
|